Available today
FDA-cleared PSWT devices
ActiPatch® and RecoveryRx® are commercial devices for their labeled pain uses. This is the current product foundation.
Current productsAI-assisted research
Discovery R&D,built AI-native.
Electrome connects scientific evidence, AI-assisted research, signal modeling, protocol design, controlled experiments, statistical validation, and documentation in one human-led learning loop.
Research workflow
01EvidenceGround the question
02ComputeRank and model
03ExperimentTest in the lab
04ValidateReplicate and review
05DocumentPublish or stop
Conceptual research workflow. AI supports the work; scientists own the decisions.
One platform, two realities
A commercial foundation. A research engine.
Pain is Electrome's first commercial focus. FDA-cleared devices establish a real operating foundation while Discovery R&D investigates what bioelectric medicine could become.
Research platform
MATRIX Discovery
Operating internal AI-native R&D software for evidence, candidate ranking, modeling, controlled laboratory experiments, replication, publication, and documentation, all under a human scientific release gate.
Explore the scienceDiscovery R&D pipeline
From a research question to evidence that can stand up to review.
- 01Available today
Define the research question
Scientists set a bounded biological question, success criteria, and interpretation limits.
- 02Available today
Discover the literature
Specialized research agents search and organize public scientific evidence for review.
- 03Available today
Extract and rank evidence
Evidence is grounded to sources, compared for quality, and ranked without replacing scientific judgment.
- 04Available today
Generate and challenge hypotheses
Agents work adaptively in parallel and sequence to propose, compare, and challenge candidate explanations.
- 05Available today
Model and simulate signals
Mathematical and statistical models help scientists explore candidate signal-response relationships.
- 06Available today
Design a controlled protocol
Scientists translate selected candidates into reproducible laboratory protocols and review gates.
- 07Available today
Run hardware-controlled experiments
Defined signals are delivered in controlled wet-lab studies; instruments record experimental observations.
- 08Available today
Validate and replicate
Researchers apply statistical checks, replication, negative controls, and human interpretation.
- 09Available today
Publish and document
Results that clear scientific review can advance to peer review, publication, and regulatory documentation.
- 10In development
Expand the learning loop
The roadmap links validated evidence back into improved models and future programmable delivery research.
Specialized AI tools support the research workflow.
MATRIX Discovery supports research under human scientific oversight and is not an autonomous scientist. It does not diagnose, monitor, or treat a person.
Evidence grounding
AI-assisted tools help search, extract, compare, and rank scientific evidence while preserving links to source material.
Research workflow support
Specialized AI tools can support parallel and sequential research tasks as scientists direct the workflow.
Modeling and simulation
Mathematical and statistical models help scientists compare candidate signal-response relationships before experiments.
Human scientific review
Scientists define the question, inspect assumptions, operate experiments, interpret findings, and decide what advances.
Maturity map
Clear about what exists and what does not yet.
Commercial and research foundation
- FDA-cleared PSWT devices for labeled pain uses
- MATRIX Discovery internal R&D software
- AI-assisted evidence, candidate ranking, and protocol work
- Controlled wet-lab experimentation and statistical review
A deeper learning loop
- Expanded research programs
- Stronger model-to-experiment feedback
- Additional validation and documentation workflows
- MATRIX System mat research and bench prototyping
Programmable therapeutic delivery
- Proposed Scan → Diagnose → Compute loop
- Human-authorized Treat → Measure → Adapt
- Treat again only after review
- Validation and an appropriate regulatory pathway before use
First end-to-end proof point
A pipeline-selected candidate reached peer review.
A platform-selected candidate produced a measurable, replicated in-vitro result on the first day of experiments; peer-reviewed publication followed approximately six months after the initial laboratory work.
This preclinical in-vitro result does not establish a Lyme disease treatment, cure, clinical efficacy, or use in people. No Electrome product is cleared or marketed for Lyme disease or any infectious condition.
Frontiers in Medicine · August 11, 2026Preclinical · In vitro · Research only
Arresting spirochetes: nonthermal extremely low-frequency electromagnetic field exposure suppresses Borrelia burgdorferi motility in vitro
Erik A. Nilsen, Heather Adkison, John R. Martinez, Nevena Zubcevik, and Monica E. Embers
Division of Immunology at the Tulane National Biomedical Research Center, Tulane University
MATRIX Discovery and GrowthOS serve different purposes.
MATRIX Discovery is internal R&D software supporting therapeutic research. GrowthOS is Electrome's separate internal, human-governed commercialization and operating infrastructure. It coordinates company work; it is not a patient-care or scientific decision-making system.